Nature of Operations and Basis of Presentation - Details 2 (Details) $ in Thousands	8 Months Ended
Sep. 30, 2024 USD ($)
Nature of Operations and Basis of Presentation [Line Items]
Opening accumulated deficit	$ 45,600
Research and development, percentage	45.00%
Opening cash balance	$ 960
Operating cash	3,400
Cash and accumulated deficit	71,600
Maximum [Member]
Nature of Operations and Basis of Presentation [Line Items]
Opening cash balance	1,880
Minimum [Member]
Nature of Operations and Basis of Presentation [Line Items]
Opening cash balance	$ 920

Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12A
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Name:	us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration